To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Statistics)
Government Office for Science

Jul. 30 2024

Source Page: Microbiome manipulation
Document: (PDF)

Found: Akkermansia have been associated with thinning of the intestinal wall (Qu, et al., 2023) and kidney disease

Arms Length Body Publication (In consultation)
NICE

Jul. 30 2024

Source Page: Maternal and child nutrition
Publication Type: Draft guidance consultation
Document: Evidence review: O PDF 9 MB (webpage)

Found: , food intolerances or allergies, inflammatory bowel disease • Parents/caregivers with language difficulties

Arms Length Body Publication (In development)
NICE

Jul. 30 2024

Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: Final scope PDF 186 KB (webpage)

Found: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238

Arms Length Body Publication (In development)
NICE

Jul. 30 2024

Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: Provisional stakeholder list (post-referral) PDF 169 KB (webpage)

Found: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238

Arms Length Body Publication (In development)
NICE

Jul. 30 2024

Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: Equality impact assessment (scoping) PDF 129 KB (webpage)

Found: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238

Arms Length Body Publication (In development)
NICE

Jul. 30 2024

Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: NICE's response to comments on the draft scope and provisional stakeholder list PDF 226 KB (webpage)

Found: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238

Arms Length Body Publication (Published)
NICE

Jul. 29 2024

Source Page: Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapy
Publication Type: Supporting evidence
Document: Final draft guidance committee papers (PDF 2.58 MB) (webpage)

Found: Capecitabine caused bowel obstruction and put me in hospital.

Parliamentary Research
Sexual and reproductive health statistics for England - CBP-10049
Jul. 18 2024

Found: and liver cancer • recurrent genital herpes • recurrent genital warts • pelvic inflammatory disease

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jul. 16 2024

Source Page: Freedom of Information responses from the MHRA: 22 January 2024
Document: (PDF)

Found: Risk factors for the disease: LHON is a maternally inherited disease and is associated with mt -DNA

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jul. 16 2024

Source Page: Freedom of Information responses from the MHRA: 8 January 2024
Document: (PDF)

Found: 2 0 Inflammatory bowel disease 1 0 Dental pain and sensation disorders Dental discomfort